Tianjin Ringpu Bio Tech (300119) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million ≈ $15.37 Million USD) by net assets (CN¥5.15 Billion ≈ $753.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tianjin Ringpu Bio Tech - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300119 current and long-term liabilities for a breakdown of total debt and financial obligations.

Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tibet GaoZheng Explosive Co Ltd SHE:002827	0.013x
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	-0.006x
Rush Enterprises B Inc NASDAQ:RUSHB	0.051x
Strait Innovation Internet Co Ltd SHE:300300	-0.181x
Power HF Co Ltd SHG:605100	0.060x
IRSA Inversiones y Representaciones SA BA:IRSA	0.001x
Monte Rosa Therapeutics Inc NASDAQ:GLUE	0.409x
Hna-Caissa Travel Group Co Ltd SHE:000796	-0.104x

Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300119 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.01 Billion ≈ $732.68 Million	CN¥735.55 Million ≈ $107.63 Million	0.147x	+86.64%
2023-12-31	CN¥4.80 Billion ≈ $703.11 Million	CN¥378.20 Million ≈ $55.34 Million	0.079x	-9.04%
2022-12-31	CN¥4.50 Billion ≈ $658.65 Million	CN¥389.49 Million ≈ $56.99 Million	0.087x	-2.22%
2021-12-31	CN¥4.32 Billion ≈ $632.69 Million	CN¥382.63 Million ≈ $55.99 Million	0.088x	-37.64%
2020-12-31	CN¥2.74 Billion ≈ $400.51 Million	CN¥388.44 Million ≈ $56.84 Million	0.142x	-12.80%
2019-12-31	CN¥2.36 Billion ≈ $344.92 Million	CN¥383.61 Million ≈ $56.13 Million	0.163x	+109.80%
2018-12-31	CN¥2.25 Billion ≈ $329.89 Million	CN¥174.88 Million ≈ $25.59 Million	0.078x	+56.93%
2017-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥107.57 Million ≈ $15.74 Million	0.049x	-49.89%
2016-12-31	CN¥2.11 Billion ≈ $308.09 Million	CN¥207.67 Million ≈ $30.39 Million	0.099x	-22.55%
2015-12-31	CN¥1.77 Billion ≈ $258.84 Million	CN¥225.27 Million ≈ $32.96 Million	0.127x	+71.20%
2014-12-31	CN¥1.73 Billion ≈ $252.53 Million	CN¥128.37 Million ≈ $18.78 Million	0.074x	+44.29%
2013-12-31	CN¥1.72 Billion ≈ $251.73 Million	CN¥88.68 Million ≈ $12.98 Million	0.052x	-9.05%
2012-12-31	CN¥1.59 Billion ≈ $232.13 Million	CN¥89.92 Million ≈ $13.16 Million	0.057x	-6.07%
2011-12-31	CN¥1.50 Billion ≈ $218.92 Million	CN¥90.29 Million ≈ $13.21 Million	0.060x	-23.68%
2010-12-31	CN¥1.43 Billion ≈ $208.78 Million	CN¥112.82 Million ≈ $16.51 Million	0.079x	-69.09%
2009-12-31	CN¥252.48 Million ≈ $36.95 Million	CN¥64.59 Million ≈ $9.45 Million	0.256x	-6.06%
2008-12-31	CN¥249.97 Million ≈ $36.58 Million	CN¥68.07 Million ≈ $9.96 Million	0.272x	+93.74%
2007-12-31	CN¥136.21 Million ≈ $19.93 Million	CN¥19.15 Million ≈ $2.80 Million	0.141x	--

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.22 Billion

CN¥8.37 Billion CNY

Market Cap Rank

#8253 Global

#2102 in China

Share Price

CN¥18.00

Change (1 day)

-0.77%

52-Week Range

CN¥17.11 - CN¥26.80

All Time High

CN¥39.94